Merck KGaA makes largest deal in a decade in $11.3B buy for Bio-Techne

Merck KGaA to acquire Bio-Techne for $11.3B, its largest deal in a decade, expanding in life science tools, spatial biology and diagnostics. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push…

Source: Endpoints News